Urolithiasis, one of the most prevalent urological conditions worldwide, significantly affects patients’ quality of life. In the United States, its lifetime prevalence is approximately 1 in 11, while global rates vary from 1% to 13%. The management of urolithiasis offers...
Transition supports continuity of supply and aligns ialuril® with IBSA’s expanding UK uro-gynaecology portfolio. Watford, UK – IBSA UK&I, the UK subsidiary of Swiss pharmaceutical company IBSA, today announces that it will assume direct responsibility for the commercialisation and distribution...
Men’s health has lagged behind its female equivalent as a specific medical subject but, over the past decade, campaigns by men’s health groups have started to give it the prominence it deserves. This book sets out to be a comprehensive...
Past India has the largest population in the world, standing at 1.43 billion as of September 2023. This vast population across a huge geographical area brings unique healthcare challenges, including the full range of urologic conditions. Urology is a relatively...
Most hypospadias repairs are undertaken on a day case ambulatory basis. Roth et al. have studied clinically significant events occurring within 30 days of operation. Data was obtained from the Paediatric Health Information System (PHIS), an administrative database that contains...
The COVID-19 pandemic has affected all aspects of our lives. We have seen huge changes in the health service, medical practice and hospital working. Many urology meetings – national and international – were cancelled and seminars and courses have become...
UroShield™ is a breakthrough disposable ultrasound device developed to prevent catheter blockages and biofilm formation, resulting in a reduction in Urinary Tract Infections (UTI) and therefore reducing the need for antibiotics, improving patient outcomes and lowering healthcare costs.
We are a manufacturer and supplier of continence care products with a difference. Our products are often designed by patients and healthcare professionals with innovative and unique features and benefits.
The rising cost of cancer care is a growing concern for health systems. A 2020 study estimated Europe’s annual cancer-related expenditure at €199 billion, with €109 billion attributed to healthcare costs. Bladder cancer (BC), in particular, imposes a significant financial...
Often, men’s health gets overlooked. Studies show that men, particularly between the ages of 15 and 60, rarely seek medical help. So, when they do, it’s important that we are able to provide them with the best possible care. If...
Why attend? Hear from Ms Rhana Zakri, Consultant Urologist at Guy's and St Thomas' NHS Foundation Trust, on the latest advances in renal transplantation Explore six shortlisted quality improvement and service transformation projects presented by resident doctors Learn how innovative...
Why attend? Hear from leading experts including Professor Axel Heidenreich, Professor Robert Huddart, Professor Vaibhav Modgil and Professor Nicholas Watkin Gain updates on advances in erectile dysfunction management, Peyronie’s disease and other benign andrological conditions Gain an up-to-date understanding of...